Lazard Asset Management’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$675K Buy
+124,555
New +$573K ﹤0.01% 1343
2024
Q4
Sell
-1,394
Closed -$8K 2514
2024
Q3
$8K Sell
1,394
-7,727
-85% -$52K ﹤0.01% 2040
2024
Q2
$60K Sell
9,121
-7
-0.1% -$41 ﹤0.01% 1893
2024
Q1
$48K Sell
9,128
-654
-7% -$3.08K ﹤0.01% 1725
2023
Q4
$50K Buy
+9,782
New +$30.2K ﹤0.01% 1892
2023
Q1
Sell
-4,499
Closed -$54K 2520
2022
Q4
$54K Buy
+4,499
New +$42.8K ﹤0.01% 1778

Other funds holding SGHT

Lazard Asset Management's SGHT Position: Q2 2026 in Review

Lazard Asset Management opened a new position in Sight Sciences (SGHT) in Q2 2026: 124,555 shares worth $675K. The stake represents ﹤0.01% of the portfolio and ranks #1343 among its holdings. This is a return to the name: Lazard Asset Management previously reported a position in SGHT as recently as Q3 2024.

Lazard Asset Management first reported a position in SGHT in Q4 2022 and has held it in 6 quarters since. 111 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Lazard Asset Management held 124,555 shares of Sight Sciences worth $675K as of Q2 2026.
  • Sight Sciences was a new Lazard Asset Management position in Q2 2026.
  • Sight Sciences made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1343 holding.
  • Lazard Asset Management first reported a position in Sight Sciences in Q4 2022 and has held it in 6 quarters since.
  • 111 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.